Trials / Unknown
UnknownNCT04956419
A Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis
A Randomized, Double-Blind, Double-Dummy, Parallel-Group, Fluconazole Controlled, Multicenter Phase III Clinical Study to Evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole in Subjects With Acute Vulvovaginal Candidiasis (VVC)
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 322 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- Female
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the Efficacy and Safety of SHR8008 vs. Fluconazole In Subjects with Acute vulvovaginal Candidiasis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR8008 capsule | once daily for 2 days(Day 1 and Day 2),oral |
| DRUG | Fluconazole capsule | once daily for 2 days(Every 72 hours) ,oral |
Timeline
- Start date
- 2021-04-24
- Primary completion
- 2021-09-30
- Completion
- 2021-09-30
- First posted
- 2021-07-09
- Last updated
- 2021-09-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04956419. Inclusion in this directory is not an endorsement.